(Q77734464)
Statements
Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors (English)
Weinberg MS
Weinberg AJ
1 September 2000